The single breath transfer factor for carbon monoxide (TLCO) 
TLCO was accounted for by expressing TLCO as a percentage of the expected value-that is, of the value expected from the reported cigarette consumption. The 63 subjects who gave a history of physician confirmed asthma in reply to a questionnaire tended to The general term chronic obstructive lung disease is commonly used to describe the condition characterised by persistent airflow obstruction. A primary objective of the Tucson epidemiological study of respiratory health' has been to elucidate the nature of chronic airflow obstruction and the associated risk factors. It has become apparent that chronic obstructive lung disease is not a single disease in our population sample and that it may take more than one form. Subjects with asthma appear to develop a different form of disease than cigarette smokers without known asthma. The degree of ventilatory impairment may be similar in all forms of the disease, but the antecedent risk factors, course, and prognosis appear to differ.23 Subjects with airflow obstruction who report a diagnosis of "asthma" have been shown to share as risk factors atopy, eosinophilia, and a raised serum IgE level. In the absence of such a diagnosis of asthma these risk factors are not significant predictors of airflow obstruction. Subjects with an apparently asthmatic form of severe chronic airways obstruction also appear to have a much better prognosis than those with smoking related "chronic obstructive lung disease." The former appear to have a form of the disease that may be called chronic asthmatic bronchitis, to distinguish it from emphysematous forms of chronic obstructive lung disease.
To determine whether the results of the single breath carbon monoxide transfer factor (TLCO) test differ in subjects with chronic asthmatic bronchitis and in those with other forms of obstructive disease, we examined the results of this test in a randomly selected Tucson community population sample. We also sought to determine whether subjects with airflow obstruction but without a diagnosis of asthma have a low TLCO, consistent with emphysema.
Methods
All subjects had been enrolled in a random, stratified, cluster sample of the white nonMexican American population of Tucson, Arizona, which is being followed in a prospective epidemiological study of respiratory health.' The single breath carbon monoxide transfer factor (TLCO) was measured during the seventh successive survey of the population, beginning in October 1981, and, to maximise participation, also during the following survey, which ended in May 1984. The surveys included standard spirometric testing4 and health information obtained from self administered questionnaires. In subjects who had had a recent acute respiratory problem (whether an asthma attack or an acute respiratory illness) at the time of interview, testing was postponed until the subject was back to what he or she regarded as "normal. 85%). These were omitted from the analysis. Of the remaining 314 subjects who were categorised as symptomatic, seven said they had both "emphysema" and "asthma." They appeared to have a more severe form of disease but were too few for useful statistical analysis and were also excluded from the The 63 subjects who reported a diagnosis of "asthma" and the remainder of the population were again classified by FEVI/FVC. The influence of a diagnosis of asthma on 00 expected TLCo are shown in figure la. Subjects with We examined further the influence of smoking by using the % expected TLCO to separate the independent effect of smoking from the effect related to a disease caused by smoking. Subjects with a diagnosis of asthma had well preserved expected TLCO whether or not they smoked. The differences in % expected TLCO between the 23 subjects with a diagnosis of asthma who had smoked and the 40 who had not smoked were not significant either for the total group or when they were grouped by FEVI/FVC. Data from subjects with a diagnosis of asthma, regardless of smoking history, have therefore been compared with the data from non-asthmatic non-smokers and nonasthmatic smokers, data from the entire population sample being used (fig 2) . The TLCO % expected was greater in those with a diagnosis ofasthma than in non-asthmatic nonsmokers (p < 0 05) and smokers (p < 0O01) and the value in. non-asthmatic non-smokers was greater than in smokers (p < 0 01). The same comparisons by FEV,/FVC subgroup are shown in figure 3, 11 reported a diagnosis of "emphysema" and their mean 00 expected TLco did not differ from that of the remaining 42 (fig 3) . Two subjects who reported a diagnosis of "emphysema" appeared among the 463 non-smokers with an FEV,/FVC of 75 0 or more and a well preserved TLCO.
Finally, we examined the relations between other diagnoses and respiratory symptoms and TLCO. Asymptomatic subjects, on average, had better lung function than those categorised as symptomatic. From answers to the self administered questionnaire 5.0%0 of the population of 1174 subjects tested had dyspnoea on exertion and 4.70 had attacks of shortness of breath with wheeze. Subjects with these complaints had significantly lower % expected TLCO than the remainder of the population. The expected TLCO in the 5.3%0 of the population sample who indicated that they had "chronic bronchitis" did not, however, differ significantly from that of the remainder of the population.
When the analysis was confined to symptomatic subjects, a given diagnosis of asthma or emphysema or both distinguished separate subgroups. When subjects with these diagnoses were excluded from the symptomatic subjects, the % expected TLCO did not distin- Knudson, Kaltenborn, Burrows guish those with exertional dyspnoea or attacks of shortness of breath with wheeze from those without these complaints. In the absence of a specific diagnosis of asthma or emphysema or both, those with other respiratory symptoms or diagnoses did not differ significantly in 0%
expected TLCO from those who were considered symptomatic because of non-respiratory disease (table 2) .
Discussion
In this study a diagnosis of asthma or emphysema was derived from answers to a self administered questionnaire used in an epidemiological study. We do not therefore know the basis for the diagnosis in each case. figure 3 , the nonasthmatic smokers with diminished ventilatory function appear to have a reduced TLco even when this value is corrected for smoking. Only 11 of these 53 subjects reported a diagnosis of emphysema. We believe, therefore, that many of these subjects are likely to have an emphysematous form of airflow obstruction that has not yet received a diagnostic label.
In our subjects with a diagnosis ofasthma the TLco and TLCO/VA were not only well preserved but, as shown in the tables and figures, above 1000() of the expected values and higher than in any other group, including the asymptomatic subjects (p < 0-01). This observation, based on our randomly selected community population sample, is consistent with previous data obtained from patients in clinical or hospital based studies."' In these studies an increase in TLCO in asthma appeared to be associated with airflow obstruction and was observed to decrease with relief of obstruction by aerosol bronchodilator."" The physiological changes underlying this association have been investigated. Keens and coworkers9 found an increase in single breath TLCO in normal subjects when the test was carried out with an inspiratory obstruction in the circuit. They suggested that the more negative intrathoracic pressure during inspiration associated with the airway obstruction increased pulmonary capillary blood volume (Vc). Stewart" measured pulmonary capillary blood volume in healthy subjects and asthmatic patients with mild airflow obstruction and found TLco and Vc/VA to be higher in the asthmatic group and to increase with increasing airflow obstruction. These observations may explain the increase in TLco associated with asthma that we and others have observed. In summary, subjects in our population sample who show chronic airflow obstruction appear to have different forms of disease, characterised by different physiological features, as well as different risk factors and clinical courses. The single breath carbon monoxide transfer factor was well preserved or raised in subjects given a diagnosis of asthma even when ventilatory function was impaired. On the other hand, most subjects with chronic airflow obstruction and reduced TLCO were cigarette smokers without a diagnosis of asthma. They are likely to include many with an emphysematous form of disease.
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